Based in Issaquah, Washington, Olympic is a commercial stage medical device company leveraging expertise in neuromodulation and energy based technology to discover, develop and commercialize novel therapies to treat ocular diseases with high unmet needs. The company’s first product iTEAR100, cleared by FDA in 2020 is an external neuromodulation device to increase natural tear production by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Our leadership team brings extensive experience in developing and commercializing treatments for ophthalmic and other disease categories.
Location: United States, Washington, Issaquah
Employees: 1-10
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | BioStar Ca... | biostar.ca... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 07.06.2021 | Arctic Vision Announces Exclusive Licensing Agreement with O... | ISSAQUAH, Wash. and SHANGHAI, June 7, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech c... | en.prnasia... |
| 07.06.2021 | Arctic Vision : Announces Exclusive Licensing Agreement with... | ISSAQUAH, Wash. and SHANGHAI, June 6, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech c... | marketscre... |
| 06.06.2021 | Arctic Vision Announces Exclusive Licensing Agreement with O... | ISSAQUAH, Wash. and SHANGHAI, June 6, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech... | prnewswire... |